Biomarkers have become widely used in the treatment of heart failure. As we better understand the role of biomarkers, their use has begun to...

Listen to an interview with Carolyn Compton, PhD, speak on quality standards surrounding human biospecimens...

Diagnostics are a critical challenge of the health care. It is especially true for the infectious diseases because of the antibiotic-resistance...

Do you ever feel frustrated that your work is not recognized? You publish a paper that reflects the last 2 years of your research and no one pays...

The legislation is getting more and more severe about pollutants. Thus, the need to analyze ambient air, water or waste arises equally. The...

In this guide, Manuel Duval, PhD, from Scientist.com looks at how pharma and biopharma companies can best prepare for the impact of big data in...

Drug discovery is long and costly: bringing a new drug to market can take 15 years and cost over $2 billion. It is also risky: of the thousands of...

A B2B marketplace that connects researchers at major pharmaceutical companies and the National Institutes of Health with scientific service providers...

Biotech startups are being urged to pitch for a new accelerator designed to advance solutions for diseases of the central nervous system (CNS...

The European Court of Justice declaring the US-EU Safe Harbor Framework to be invalid led to the adoption of the EU-US and Swiss-US Privacy Shield...